Skip to content

Patient Empowerment With the Patient Perspective

PEPP - Patient Empowerment With the Patient Perspective

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03654950
Acronym
PEPP
Enrollment
200
Registered
2018-08-31
Start date
2018-06-01
Completion date
2021-12-01
Last updated
2022-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Brief summary

The overall aim with this study is to gain a deeper understanding of patient perceptions regarding empowerment in relation to a health platform.

Detailed description

This is a two-stage study design. The first stage consists of focus groups interviews. Three focus groups with 6-8 patients (colorectal cancer patients diagnosed at least one year ago) in each group, will be invited. The focus group interviews will be moderated by one researcher, but accompanied with a second observing researcher. The participants will be identified using the regional Swedish ColoRectal Cancer Registry in Västra Götaland. The participants will be contacted by a short letter (appendix) indicating that we will call them with more information. The participants will by phone be asked to participate in the study and then invited to the focus groups. The second phase of the project includes a questionnaire, which will be sent to 200 patients from the same population. The questionnaires will be delivered by using the Sunet Survey system, which is a system approved by University of Gothenburg. If the participants prefers a paper copy, or lack the possibility to reply online, a paper copy will be send via mail instead. At this moment the investigators have developed a questionnaire, which may be refined due to the understating achieved from the focus group interviews.

Interventions

OTHERNo intervention

Interviews and questionnaires

Sponsors

Högskolan Väst
CollaboratorUNKNOWN
Sahlgrenska University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient with colorectal cancer

Exclusion criteria

* Inability to give informed consent or speaking and reading the Swedish language.

Design outcomes

Primary

MeasureTime frameDescription
Patient reported experiences in themes1 dayinterview

Secondary

MeasureTime frameDescription
Patient reported experiences divided into themes12 monthsInterview

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026